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A B S T R A C T
A 35-year-old male presented with Candida keratitis in the left eye. He was HIV positive with a CD4 of 352 cells/
µL. The eye quickly deteriorated, despite intensive antifungal treatment and was eviscerated. Five months later,
he re-presented with Candida keratitis in his right eye. A focal source of Candida infection was suspected and a
urine culture identiﬁed Candida spp, despite being asymptomatic for genitourinary candidiasis. He was subse-
quently treated with good outcome (max. 75 words)
1. Introduction
Microbial keratitis (MK) is caused by a range of pathogens, in-
cluding bacteria, viruses, protozoa and fungi. It is characterized by
pain, conjunctival hyperemia and corneal ulceration with stromal in-
ﬂammatory cell inﬁltrate. MK frequently leads to sight-loss from dense
corneal scarring or even loss of the eye when severe.
In tropical regions approximately half of MK is attributable to fungal
pathogens [1,2]. Filamentous organisms predominate, with Fusarium
spp. and Aspergillus spp. accounting for the large majority [3]. Yeast
infections, mostly caused by Candida spp are less frequent. In contrast,
in temperate regions yeast often predominate, although some recent
reports suggest an increasing proportion of ﬁlamentous infections [4].
Reported risk factors for fungal keratitis include trauma, ocular surface
disease, contact lens use, prior surgery, traditional eye medicine (TEM),
steroid use and immunosuppression [4–6].
Candida keratitis is particularly associated with chronic ocular
surface disease and has been reported following various corneal pro-
cedures [4,7,8]. Although the source of the Candida is usually exo-
genous, it may sometimes have an endogenous source such as from the
oral and genitourinary surfaces or a disseminated systemic infection in
severely immunocompromised individuals [9,10]. Genitourinary Can-
dida infection is relatively common in Africa; it can be either sympto-
matic or asymptomatic [11]. It is reported to contribute 30–50% of all
cases treated with genitourinary infection [11–14]. However, it has not
been previously reported to be associated with keratitis.
Here we report a case of a 35-year-old man with sequential bilateral
Candida keratitis with a concomitant asymptomatic genitourinary
Candida infection. This provides important lessons on investigation,
treatment and preventative care in similar cases.
2. Case
2.1. First eye presentation
A 35-year-old male Ugandan presented to Mbarara University
Referral Hospital Eye Centre (MURHEC) in June 2017 with a 10-day
history of a painful, red left eye. There was no history of trauma,
contact lens or TEM use. He was not aware of his HIV status at the time
of presentation, but thought that he was HIV negative. He described a
somewhat similar eye problem in his teenage years, which followed
trauma, was treated and had healed. He had experienced no further
ocular problems until this new presentation.
On this admission (day0),the left visual acuity was hand movements
only, with no improvement on pinhole. There was a dense white
paraxial supratemporal corneal inﬁltrate (2.0 mm×1.5mm), an
overlying epithelial defect (2.0 mm×1.5mm), 80% corneal thinning
and a 3.5 mm hypopyon (Fig. 1a). Additionally, the left cornea had an
old inferior vascularized scar (7 mm×6mm). The right eye had an
unaided visual acuity of 6/5 and normal ocular examination.
Corneal scrapings were collected for microscopy (Gram stain,
Potassium Hydroxide [KOH] stain, Calcoﬂuor White [CFW] stain,
Lactophenol Cotton Blue stain[LPCB]) and culture (Blood Agar [BA],
Chocolate Agar [CA], Potato Dextrose Agar [PDA] and Brain Heart
Infusion [BHI]). Initial CFW slide revealed fungal elements. The Gram,
KOH and LPCB tests were negative. However, Candida spp. grew on BA,
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PDA, CA and BHI subculture within 48 h.
The patient was started on hourly Natamycin 5% eyedrops (Zonat
Sunways India) as well as Oﬂoxacin 0.3% eyedrops (Biomedica
Remedies-India) 4 times/day and Atropine eyedrops. By day3, the eye
had rapidly deteriorated (Fig. 1b) and hourly Chlorohexidine 0.2%
eyedrops (locally formulated) was added to his treatment. By day7 the
cornea had thinned further and was threatening to perforate (Fig. 1c).
Corneal tissue for transplantation is currently unavailable in Uganda.
On day8, a conjunctival ﬂap procedure was performed (Fig. 1d), in
conjunction with a subconjunctival injection of Fluconazole 2%
(0.5 ml). On day21, he returned with a total corneal and conjunctival
ﬂap melt (Fig. 1e). At this stage further active treatment was considered
futile and a decision was taken with the patient to perform an evis-
ceration. Subsequently, a prosthetic shell was ﬁtted.
It is our routine practice to oﬀer HIV counselling and testing to all
people presenting with MK. This individual accepted the oﬀer and was
found to be HIV positive. He was referred to HIV services and started
anti-retroviral therapy. His CD4 count was 352 cells/µL around the time
treatment was initiated.
2.2. Second eye presentation
Five months later, he returned to MURHEC with a 4 day history of a
painful right eye. Again, there was no history of trauma, contact lens or
TEM use. On this day0 for the righteye presentation, visual acuity in the
right eye was 6/12. Slit lamp examination showed a supra-temporal
dense corneal inﬁltrate (3.1 mm×2.8mm), Fig. 2a. Corneal scrape
samples were collected and sent for microbiological investigations, as
outlined above. Gram stain showed pseudo-hyphae. CFW and KOH
reported fungal hyphae and all culture plates (BHI subculture, BA, CA,
PDA) grew Candida spp. The same ﬁrst line protocol as previous (Na-
tamycin, Oﬂoxacin and Atropine) was started. At this point, we were
concerned that he might have a source of Candida elsewhere, that had
led to the sequential corneal infections. He reported no systemic
symptoms; speciﬁcally he did not have dysuria. As part of the assess-
ment a urine sample was cultured, which also grew Candida spp.
By day3 we noted a moderate deterioration (Fig. 2b). Therefore, we
added hourly Amphotericin B 0.15% eyedrops (locally formulated with
a hyper methylcellolose base) and oral ﬂuconazole 200mg twice a day
to his treatment. By day21, the ocular pain had greatly reduced and the
inﬁltrate had transitioned into a scar extending to the visual axis
(7 mm×4mm). He developed a small para-central perforation. This
self-sealed with iris plugging; the anterior chamber was deep and Sie-
del's test was negative (Fig. 2c). By 3 months (day90) the scar size had
reduced slightly (6 mm×3.2mm), and his right visual acuity was 6/
24.
Fig. 1. (a–e) showing appearance of the left eye from presentation (day0) to day21, in June 2017.
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3. Discussion
Although Candida keratitis has generally been found to be more
common in temperate climates, it has been reported, albeit less fre-
quently, in tropical regions [1,2,15]. This patient presented us a unique
opportunity to reﬂect on the presentation of Candida keratitis in HIV
infected patients and identify key considerations to ensure a good
outcome.
Firstly, the patient had undiagnosed HIV infection with a relatively
low CD4 count which could have predisposed him to the initial infec-
tion. We routinely provide HIV counselling and testing to MK patients
as part of our hospital protocol, based on previous studies in the region
that noted a high proportion of MK patients with HIV [16,17]. This is
consistent with our experience in Uganda, where we ﬁnd in ongoing
case-control work HIV is more frequent in people with MK (un-
published data).
Secondly, we did not initially suspect a systemic source of the
Candida infection. The patient was asymptomatic for this.
Endophthalmitis resulting from Candida septicemia is well character-
ized [10,18,19]. Blood culture for Candida septicemia was not per-
formed in our patient because he was afebrile, he did not have oral
thrush and otherwise clinically well. Patients with Candida septicemia
are usually very sick at presentation; they require hospitalization, with
a majority requiring intensive care treatment [18]. Our patient was
found to have asymptomatic genitourinary candidiasis on urine culture.
Therefore, we think that the most likely explanation for the acquisition
of his sequential case bilateral Candida keratitis was due to poor hy-
giene.
Thirdly, our patient rapidly deteriorated on the ﬁrst presentation
resulting loss of the eye, despite intensive treatment with two anti-
fungal agents. Candida keratitis rapidly causes corneal perforations,
corneal scars, endophthalmitis and loss of vision in many cases [20].
However, experience of managing his ﬁrst infection helped us to ag-
gressively manage his remaining eye when it became infected. Prompt
microbiological conﬁrmation of the Candida helped to initiate a dual
drug combination of hourly Natamycin 5% eyedrops and Amphotericin
B 0.15% eyedrops. We were able to save the eye and preserve useful
vision. Molecular strain typing which would be required to validate if
there was any similarity among the isolates, was not available.
This case graphically illustrates the increased risk to fungal keratitis
experienced by HIV positive individuals. It highlights the need in
unusual bilateral cases for careful assessment for a potential source
elsewhere in the body. It is a reminder of the high ocular morbidity
associated with these types of infections and the particular treatment
challenges they present
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